Loading
MS
Medidata Solutions, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by SHAPIRO LEE, was filed 17 Feb 2016.
Medidata Solutions, Inc.: what insiders have been doing
Medidata Solutions, Inc. is a listed company. Its directors and officers file their transactions with SEC (Form 4). The past year has been quiet: not a single insider filing for Medidata Solutions, Inc. The previous disclosure was published on 28 October 2019.
Looking back to 2016, when coverage begins, insiders filed 1 purchase and 104 sales.
These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
372
Thresholds
n/a
Buy Volume
€44,903
1 ops. · all time
Sell Volume
€68M
104 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2018FY ended December 2018 · cache
Income statement
Revenue566.7M
Gross profit424.8M75% margin
Net income46.3M8.2% margin
Last declaration on 28 October 2019
Declarations372 total
39,380 sharesCommon StockSEC:0001453814-19-000163:1
47,383 sharesCommon StockSEC:0001453814-19-000165:1
1,100 shares0Common StockSEC:0001453814-19-000157:0
109,195 shares0Common StockSEC:0001453814-19-000145:0
114,256 sharesCommon StockSEC:0001453814-19-000145:2
2,000 shares0Common StockSEC:0001453814-19-000161:0
29,128 sharesCommon StockSEC:0001453814-19-000161:2
110,000 shares0Common StockSEC:0001453814-19-000153:0
114,256 sharesCommon StockSEC:0001453814-19-000153:2
67,514 sharesCommon StockSEC:0001453814-19-000167:1
7,081 shares@ US$92.25100.0% of flowCommon StockSEC:0001453814-19-000155:0
11,392 shares@ US$92.2536.8% of flowCommon StockSEC:0001453814-19-000163:0
74,598 shares@ US$92.2598.8% of flowCommon StockSEC:0001453814-19-000159:0
119,161 shares@ US$92.25100.0% of flowCommon StockSEC:0001453814-19-000143:0
10,132 shares@ US$92.2523.7% of flowCommon StockSEC:0001453814-19-000165:0
73,988 shares@ US$92.2598.8% of flowCommon StockSEC:0001453814-19-000157:1
28,827 shares@ US$92.2574.6% of flowCommon StockSEC:0001453814-19-000149:0
620,750 shares@ US$92.2569.7% of flowCommon StockSEC:0001453814-19-000145:1
51,208 shares@ US$92.2553.0% of flowCommon StockSEC:0001453814-19-000161:1
41,757 shares@ US$92.2583.3% of flowCommon StockSEC:0001453814-19-000147:0
45,555 shares@ US$92.2595.4% of flowCommon StockSEC:0001453814-19-000151:0
576,031 shares@ US$92.2568.1% of flowCommon StockSEC:0001453814-19-000153:1
49,164 shares@ US$92.2527.3% of flowCommon StockSEC:0001453814-19-000167:0
4,619 shares@ US$91.9710.8% of flowCommon StockSEC:0001453814-19-000141:0
11,820 shares@ US$7.001.2% of flowCommon StockSEC:0001453814-19-000121:0
25 of 372 declarations
About Medidata Solutions, Inc.
Medidata Solutions, Inc. is a company that specializes in cloud-based clinical trial management solutions. It provides services and technologies to help pharmaceutical and biotechnology companies optimize their research and development processes.
